Fiscal Impact of HPV Prevention Strategies in Indonesia
by Didik Setiawan·Updated 6y ago
Available on 1 platform
Sign in to view source links and access this dataset
Description
Indonesia's economic analysis estimates the fiscal benefits of cervical cancer prevention for a cohort of 10,000,000 12-year-old females. The study calculates Net Present Value for vaccination, screening, and combined strategies, reporting reductions of 87,862 cervical cancer cases and 19,359 deaths.
Use Cases
Compare Net Present Value (NPV) outcomes across HPV vaccination, cervical screening, and combined intervention strategies.
Model the fiscal impact of reducing cervical cancer incidence by 87,862 cases and HPV-related mortality by 19,359 deaths.
Analyze cost-benefit scenarios for government investment in cervical cancer prevention from a public health perspective.
Strengths
Analysis is based on a defined cohort of 10,000,000 Indonesian females.
Provides concrete outcome metrics, including 87,862 estimated cervical cancer cases prevented.
Results include specific Net Present Value figures for three distinct prevention strategies.
Limitations
Dataset structure and underlying raw data columns are not provided, limiting direct analytical use.
Analysis is specific to the Indonesian context and a single cohort, limiting generalizability.
The fiscal model's assumptions and input parameters are not detailed in the available description.
Provenance
Source
Dryad
Collection Method
A government-perspective quantitative analytic framework applied to assess Net Present Value of cervical cancer prevention.
Time Range
null
Freshness
null
Geography
Indonesia
License is CC0 1.0 Public Domain Dedication. The provided information is a study summary; the availability of the underlying tabular dataset is unknown.